Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor-reported stress type affects inflammatory blood markers prior to donation.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2025
Same author

Reducing deterrents to engage in plasmapheresis donation: Evaluation of an experimental flyer.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2025
Same author

Impact of societal and legal context on the blood supply of African-ancestry populations in Western countries: A review of practices and the French example.

Vox sanguinis·2022
Same author

Noncompliance to blood donor selection criteria by men who have sex with men - Complidon 2017, France.

Vox sanguinis·2020
Same author

The evolving blood donor deferral policy for men who have sex with men: impact on the risk of HIV transmission by transfusion in France.

Transfusion·2020
Same author

Noncompliance with blood donor selection criteria - Complidon 2017, France.

Transfusion·2019

Related Experiment Video

Updated: Jul 14, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

[Haemovigilance donors: methods and results].

Danielle Rebibo1, Bruno Danic

  • 1Etablissement français du sang, direction médicale et scientifique, pôle vigilance, 20 avenue du Stade-de-France, 93218 La Plaine Saint-Denis cedex, France. danielle.rebibo@efs.sante.fr

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|May 22, 2007
PubMed
Summary

Haemovigilance in blood donation monitors serious adverse events and infections. Data shows vasovagal reactions are common, while infectious risks like HIV and HCV are decreasing significantly.

More Related Videos

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
04:43

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

Published on: June 24, 2025

Related Experiment Videos

Last Updated: Jul 14, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
11:59

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
04:43

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah

Published on: June 24, 2025

Area of Science:

  • Transfusion Medicine
  • Public Health
  • Epidemiology

Background:

  • Haemovigilance focuses on blood donor safety, including Serious Adverse Events in Donors (SAEDs), Post Donation Information (PDI), and epidemiological surveys.
  • French regulations mandate SAED reporting, highlighting the importance of donor safety in blood transfusion services.

Purpose of the Study:

  • To analyze national data on blood donor safety, including SAEDs, PDIs, and infectious risks.
  • To identify donor populations most susceptible to adverse events and assess trends in transfusion-transmitted infections.

Main Methods:

  • Retrospective analysis of national haemovigilance data from France.
  • Statistical review of reported SAEDs, PDIs, and viral residual risks for blood donations.

Main Results:

  • In 2006, 196 SAEDs were reported (7.5/100,000 donations), with women under 30, repeat, and apheresis donors being more susceptible. Vasovagal reactions were the most frequent SAED.
  • In 2005, 7,361 PDIs were reported, primarily related to infection risks (e.g., ENT).
  • Between 2003-2005, residual viral risks were low: 1/2,600,000 for HIV, 1/6,500,000 for HCV, and 1/1,000,000 for HBV, showing a decrease since 1992.

Conclusions:

  • National haemovigilance data provides valuable insights into blood donor safety.
  • Findings support improved care for blood donors and recipients, emphasizing the need for continued monitoring and risk reduction strategies.